Filana Therapeutics, Inc. Revenue 2009–2013
Filana Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2009 to 2013. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Filana Therapeutics, Inc. revenue for the quarter ending September 30, 2013 was 2.0 M, a 28.15% decrease year-over-year.
- Filana Therapeutics, Inc. revenue for the twelve months ending September 30, 2013 was 8.6 M, a 23.20% decrease year-over-year.
- Filana Therapeutics, Inc. annual revenue for 2013 was 41.1 M, a 277.58% increase from 2012.
- Filana Therapeutics, Inc. annual revenue for 2012 was 10.9 M, a 5.17% decrease from 2011.
- Filana Therapeutics, Inc. annual revenue for 2011 was 11.5 M, a 31.68% decrease from 2010.
- Filana Therapeutics, Inc. annual revenue for 2010 was 16.8 M.
Filana Therapeutics, Inc. (FLNA) — Frequently Asked Questions
Filana Therapeutics, Inc. (FLNA) is a publicly traded US company. It has a market capitalization of $60M. In fiscal 2013 it reported revenue of $41M and net income of $32M. Explore FLNA's stock price, financial statements, earnings history, margins and key ratios below.
What is Filana Therapeutics, Inc.'s market cap?
Filana Therapeutics, Inc. (FLNA) has a market capitalization of $60M.
What is the FLNA stock price?
FLNA trades at $1.32 (-7.04% on the day).
How much revenue does Filana Therapeutics, Inc. make?
Filana Therapeutics, Inc. reported revenue of $41M in fiscal 2013.
Is FLNA profitable?
In fiscal 2013, Filana Therapeutics, Inc. reported net income of $32M.
What is FLNA's P/E ratio?
Based on diluted EPS, FLNA has a price-to-earnings (P/E) ratio of about 1.9.